Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 325
Selected: 0
NCT IDTitle
NCT01352689CKD-828(80/2.5mg) Pharmacokinetic Study_2nd
NCT05952219Study to Evaluate the Safety and Pharmacokinetics of CKD-379
NCT02977065To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors
NCT04906798Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions
NCT02002611Drug-drug Interaction Study(Lobeglitazone, Warfarin)
NCT02461004CKD-391 Pharmacokinetic Study
NCT01340248A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers
NCT05544214Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects
NCT01580371Safety and Pharmacokinetic Profile of CKD-581
NCT04673864A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386
NCT04883658A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)
NCT02811731Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B
NCT07258745Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants
NCT04987970A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg
NCT05698043A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg
NCT04478097Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
NCT01028859Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers
NCT04555434Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH
NCT07304687Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers
NCT01330563Drug-drug Interaction Study (CKD-501, Ketoconazole)
NCT02300467NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors
NCT06399055Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions
NCT05816759Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150
NCT05041790A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
NCT06399068Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions
NCT02247518CKD-397 Drug-drug Interaction Study (A)
NCT05274880Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393
NCT04869800Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg
NCT04830930A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers
NCT03601910Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg
NCT05549401Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348
NCT03583905Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet
NCT01029522Dyslipidemia in Cardiovascular Disease
NCT03062059The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence
NCT03569579CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)
NCT04471441Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients.
NCT03858725Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers
NCT03793985Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337
NCT06492655To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers
NCT02854748Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin
NCT05238948CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects
NCT02801526Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A
NCT01356017CKD-828 Drug Interaction Study (Telmisartan)
NCT05335044Study to Evaluate the Safety and Pharmacokinetics of CKD-331
NCT05043467Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus
NCT06695598Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers
NCT03067194The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients
NCT04651881Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
NCT01842230Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine
NCT02480465Efficacy and Safety of Lobeglitazone Versus Sitagliptin